Insights / Media Coverage Fenwick's Tom Ensign Quoted on CVC Investing Amid Increased Federal Antitrust Enforcement November 2, 2022
Insights / Experience Fenwick Represents Amberdata in Acquisition of Genesis Volatility October 31, 2022
Insights / Experience Fenwick Represents Collide Capital in Launch of its $66M Inaugural Fund October 28, 2022
Insights / Event The Future of Reproductive Health: Building & Investing in Post-Roe America October 27, 2022
Insights / Experience Fenwick Represents UserTesting in Acquisition by Thoma Bravo and Sunstone Partners October 27, 2022
